More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1078 participants.

Also called NCT01510652

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,078 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01510652
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium, Canada, Finland, France, Germany, India, Israel, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01510652. Randomized; no masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2015-10-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges
Acronym
MORE-CRT
Condition
Postoperative Cardiac Complication
Condition
Heart Failure
Condition
Left Ventricular Cardiac Dysfunction
Condition
Inappropriate Phrenic Nerve Stimulation
Condition
Perioperative/Postoperative Complications
Intervention (Procedure)
BiP Group
Intervention (Device)
Quad Group
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01510652
Content hash
9cc400aaee0412d93c15a4fa414ab309f3ce6ff6aaad00365e6671a5e87ddbc4